for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Becton Dickinson and Co

BDX.N

Latest Trade

250.70USD

Change

3.29(+1.33%)

Volume

286,763

Today's Range

246.76

 - 

251.45

52 Week Range

219.50

 - 

284.95

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

BD Expands Voluntary Recall Of ChloraPrep 3 mL Applicator

March 24 (Reuters) - Becton Dickinson and Co <BDX.N>::BD EXPANDS VOLUNTARY RECALL OF CHLORAPREP™ 3 ML APPLICATOR NATIONWIDE TO INCLUDE ALL U.S. STATES.BECTON DICKINSON - IS IMPLEMENTING GLOBAL PACKAGING CHANGE FOR 3 ML PRODUCT TO CORRECT ISSUE, EXPECTED TO BE AVAILABLE BY END OF APRIL IN U.S..BECTON DICKINSON AND CO - IS INSTRUCTING CUSTOMERS, DISTRIBUTORS TO DISCARD ALL REMAINING INVENTORY OF IMPACTED CHLORAPREP 3 ML APPLICATORS.

BD Acquires GSL Solutions

March 4 (Reuters) - Becton Dickinson and Co <BDX.N>::BD ACQUIRES GSL SOLUTIONS, INC., BROADENING MEDICATION MANAGEMENT OFFERINGS FOR RETAIL, OUTPATIENT PHARMACY SETTINGS.BECTON DICKINSON AND CO - TERMS OF TRANSACTION WERE NOT DISCLOSED.BECTON DICKINSON AND CO - EXPECTS TRANSACTION TO BE IMMATERIAL.

Becton Dickinson Posts Q1 Adjusted Earnings Per Share $4.55

Feb 4 (Reuters) - Becton Dickinson and Co <BDX.N>::BD ANNOUNCES FIRST FISCAL QUARTER RESULTS; RAISES FISCAL 2021 GUIDANCE.Q1 ADJUSTED EARNINGS PER SHARE $4.55.Q1 GAAP EARNINGS PER SHARE $3.35.Q1 EARNINGS PER SHARE ESTIMATE $3.11 -- REFINITIV IBES DATA.SEES FY ADJUSTED EARNINGS PER SHARE $12.75 TO $12.85.Q1 REVENUE $5.315 BILLION VERSUS REFINITIV IBES ESTIMATE OF $4.88 BILLION.NOW EXPECTS FISCAL YEAR 2021 REVENUES TO GROW 12% TO 14% ON AN AS REPORTED BASIS.FY2021 EARNINGS PER SHARE VIEW $12.58 -- REFINITIV IBES DATA.NOW EXPECTS FISCAL YEAR 2021 REVENUES TO GROW 10% TO 12% ON A CURRENCY-NEUTRAL BASIS.

BD Says New Clinical Data Found Evidence That Using Vascular Care Solution Can Help Improve Outcomes For Patients Requiring Peripheral Intravenous Catheters

Feb 2 (Reuters) - Becton Dickinson and Co <BDX.N>::FIRST-OF-ITS-KIND RANDOMIZED CLINICAL TRIAL PUBLISHED IN "THE LANCET INFECTIOUS DISEASES" OUTLINES POTENTIAL NEW STANDARD-SETTING BEST PRACTICES FOR PERIPHERAL IV CATHETERS.BECTON DICKINSON - COMPARED WITH STANDARD APPROACHES, THE BD VASCULAR CARE SOLUTION REDUCED RELATIVE RISK OF CATHETER FAILURE BY 27%.BECTON DICKINSON - BD VASCULAR CARE SOLUTION REDUCED RELATIVE RISK OF CATHETER FAILURE BY 27%, RESULTING IN LONGER CATHETER DWELL TIME.BECTON DICKINSON - USE OF 2% CHG 70% IPA SINGLE USE, STERILE APPLICATOR SKIN ANTISEPTIC REDUCED RISK OF INFECTIOUS COMPLICATIONS BY 92%.

BD Names CEO Tom Polen As Chairman Of The Board

Jan 26 (Reuters) - Becton Dickinson and Co <BDX.N>::BD NAMES CEO TOM POLEN AS CHAIRMAN OF THE BOARD.BECTON DICKINSON AND CO - POLEN WILL SUCCEED VINCENT A. FORLENZA, WHO WILL RETIRE FROM BD AT THAT TIME.BECTON DICKINSON AND CO - TOM POLEN, BD CEO & PRESIDENT, TO ASSUME ADDITIONAL RESPONSIBILITY AS CHAIRMAN OF BD BOARD OF DIRECTORS, EFFECTIVE APRIL 28.

Becton Dickinson Sees Q1 2021 Revenue Of $5.3 Billion

Jan 12 (Reuters) - Becton Dickinson and Co <BDX.N>::Q1 REVENUE $5.3 BILLION VERSUS REFINITIV IBES ESTIMATE OF $4.69 BILLION.SEES Q1 2021 REVENUE $5.3 BILLION.ON A CURRENCY-NEUTRAL BASIS FIRST FISCAL QUARTER 2021 REVENUES ARE EXPECTED TO INCREASE 24.2% OVER PRIOR-YEAR PERIOD.EXPECTS COVID-19 TESTING REVENUES FOR FIRST FISCAL QUARTER OF ABOUT $865 MILLION.NOW EXPECTS FISCAL 2021 FULL YEAR REVENUE GROWTH TO BE TOWARD UPPER END OF PREVIOUSLY DISCLOSED REVENUE GUIDANCE RANGE.EXPECTS ADJUSTED NON-GAAP DILUTED EARNINGS PER SHARE TO BE ABOVE PREVIOUSLY DISCLOSED GUIDANCE RANGE FOR FISCAL 2021 FULL YEAR.

Becton Dickinson and Co Board Increases Dividend

Nov 24 (Reuters) - Becton Dickinson and Co <BDX.N>::BD BOARD INCREASES DIVIDEND.BECTON DICKINSON AND CO - DECLARED A QUARTERLY DIVIDEND OF $0.83 PER COMMON SHARE, AN INCREASE OF 5.1% FROM PREVIOUS QUARTER.

Becton Dickinson Says Aware Of The Tweet By Elon Musk And Are Reaching Out To Learn More, Consistent With Our Quality Management Process - Tweet

Nov 13 (Reuters) - :BECTON DICKINSON SAYS AWARE OF THE TWEET BY ELON MUSK AND ARE REACHING OUT TO LEARN MORE, CONSISTENT WITH OUR QUALITY MANAGEMENT PROCESS - TWEET.BECTON DICKINSON -WHILE SCIENTIFIC COMMUNITY AGREES NO DIAGNOSTIC TEST IS PERFECT, CO STANDS BEHIND QUALITY, UTILITY, SCIENCE OF CO'S SYSTEM & ASSAY.

Bd Acquires The Medical Business Assets Of Cubex LLC, Broadening Automated Dispensing Portfolio Across Care Continuum

Nov 12 (Reuters) - Becton Dickinson and Co <BDX.N>::BD ACQUIRES THE MEDICAL BUSINESS ASSETS OF CUBEX LLC, BROADENING AUTOMATED DISPENSING PORTFOLIO ACROSS CARE CONTINUUM.BECTON DICKINSON AND CO - TERMS OF TRANSACTION WERE NOT DISCLOSED.BECTON DICKINSON AND CO - ACQUISITION DOES NOT IMPACT BD'S FISCAL 2021 GUIDANCE..

Becton Dickinson Announces Q4 Non-Gaap Earnings Per Share $2.79

Nov 5 (Reuters) - Becton Dickinson and Co <BDX.N>::BD ANNOUNCES FISCAL FOURTH QUARTER AND FULL YEAR 2020 RESULTS; PROVIDES FISCAL 2021 GUIDANCE.Q4 NON-GAAP EARNINGS PER SHARE $2.79.Q4 GAAP EARNINGS PER SHARE $0.36.Q4 REVENUE $4.784 BILLION VERSUS REFINITIV IBES ESTIMATE OF $4.48 BILLION.Q4 EARNINGS PER SHARE ESTIMATE $2.52 -- REFINITIV IBES DATA.BD'S COVID-19 TESTING SALES TOTALED MORE THAN $440 MILLION IN FOURTH FISCAL QUARTER.EXPECTS FISCAL YEAR 2021 REVENUES TO GROW HIGH SINGLE TO LOW DOUBLE-DIGITS ON A PERCENTAGE BASIS.SEES FISCAL YEAR 2021 ADJUSTED DILUTED EARNINGS PER SHARE TO BE BETWEEN $12.40 AND $12.60.ADJUSTED DILUTED EARNINGS PER SHARE FOR FISCAL 2021 EXCLUDES POTENTIAL CHARGES OR GAINS THAT MAY BE RECORDED DURING FISCAL YEAR.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up